Patents by Inventor Perry Caimi

Perry Caimi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7524660
    Abstract: A process has been developed for the utilization of fructose by PTS? microorganisms. Providing the microorganisms with increased fructokinase activity, and optionally with increased fructose transport capacity, allows the microorganisms to use fructose as a nutrient supply with sustained growth. The microbial production of substances such as cell mass, glycerol, and 1,3-propanediol may be achieved during growth in a fructose containing medium using this process.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: April 28, 2009
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Perry Caimi, Charles Nakamura
  • Publication number: 20080081358
    Abstract: Xylose-utilizing Z. mobilis strains were found to have improved ethanol production when grown in medium containing mixed sugars including xylose if sorbitol or mannitol was included in the medium. The effect was seen in concentrations of mixed sugars where no growth lag period occurs, as well as in higher sugars concentrations.
    Type: Application
    Filed: September 27, 2007
    Publication date: April 3, 2008
    Inventors: PAUL VIITANEN, Carol Mc Cutchen, Xu Li, Mark Emptage, Perry Caimi, Min Zhang, Yat-Chen Chou, Mary Franden
  • Publication number: 20080009066
    Abstract: This invention relates to isolated nucleic acid fragments encoding trehalose metabolism enzymes, more specifically, alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase. The invention also relates to the construction of a recombinant DNA construct encoding all or a portion of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the alpha, alpha-trehalase, alpha, alpha-trehalose-phosphate synthase or trehalose-6-phosphate phosphatase in a transformed host cell.
    Type: Application
    Filed: March 21, 2007
    Publication date: January 10, 2008
    Inventors: Perry Caimi, J. Rafalski, Zude Weng, Anthony Kinney, Saverio Falco
  • Publication number: 20070261135
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a disease resistance factor. The invention also relates to the construction of a chimeric gene encoding all or a substantial portion of the disease resistance factor, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the disease resistance factor in a transformed host cell.
    Type: Application
    Filed: January 18, 2007
    Publication date: November 8, 2007
    Inventors: Perry Caimi, Omolayo Famodu, Jian-Ming Lee, Guo-Hua Miao, Carl Maxwell
  • Publication number: 20060252136
    Abstract: A process has been developed for the utilization of fructose by PTS? microorganisms. Providing the microorganisms with increased fructokinase activity, and optionally with increased fructose transport capacity, allows the microorganisms to use fructose as a nutrient supply with sustained growth. The microbial production of substances such as cell mass, glycerol, and 1,3-propanediol may be achieved during growth in a fructose containing medium using this process.
    Type: Application
    Filed: May 5, 2005
    Publication date: November 9, 2006
    Inventors: Perry Caimi, Charles Nakamura
  • Publication number: 20060005280
    Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.
    Type: Application
    Filed: June 8, 2005
    Publication date: January 5, 2006
    Inventors: Johan Stoop, Stephen Allen, Perry Caimi
  • Publication number: 20050102715
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a disease resistance factor. The invention also relates to the construction of a chimeric gene encoding all or a substantial portion of the disease resistance factor, in sense or anti-sense orientation, wherein expression of the chimeric gene results in production of altered levels of the disease resistance factor in a transformed host cell.
    Type: Application
    Filed: December 2, 2004
    Publication date: May 12, 2005
    Inventors: Perry Caimi, Omolayo Famodu, Jian-Ming Lee, Guo-Hua Miao, Carl Maxwell
  • Publication number: 20050010972
    Abstract: This invention relates to isolated nucleic acid fragments encoding fructosyltransferases. More specifically, this invention relates to polynucleotides encoding 1-FFTs, 6-SFTs, or 1-SSTs. The invention also relates to the construction of a recombinant DNA constructs encoding all or a portion of the fructosyltransferases, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the fructosyltransferases in a transformed host cell.
    Type: Application
    Filed: August 11, 2004
    Publication date: January 13, 2005
    Inventors: Stephen Allen, Perry Caimi, Johan Stoop